On Nov. 13, MobiHealth News reported on the results of a two-year clinical trial for HealthPROMISE. HealthPROMISE, an app-based platform developed at Mount Sinai, is designed to improve the quality of care for patients who are struggling with inflammatory bowel disease (IBD). The MobiHealth News publication was based on clinical data recently presented at the Advances in Inflammatory Bowel Diseases Conference.
HealthPROMISE is a unique, cloud-based patient reported outcome (PRO) and decision support tool that empowers patients and providers: patients track their quality of life and symptoms, while providers can use the visual data in real time through EHR integration to provide better care to the entire patient population. During the trial, researchers focused on changes in the quality of care metrics between the groups, while observing shifts in quality of life scores, discovering the proportion of patients who reported controlled disease status in each group and documenting any decreases in IBD related emergency visits and hospitalizations.
According to Dr. Ashish Atreja, HealthPROMISE improved patient health outcomes and long-term engagement by implementing tools that allow care teams to monitor symptoms and more conveniently communicate with their patients. The platform assists with the collection of symptom and adherence data, which can then be reviewed while designing care strategies. Patients using HealthPROMISE are able to update their medical information while receiving a summary of quality care metrics and quality of life trends specific to IBD.
“Patients were coming to see us once or twice a year, but a lot of times we were finding patients falling through the cracks [and] there were symptoms they had for many months before they came back to us,” Atreja said to MobiHealth News. “Three or four hours of physician-time a year is not relevant for many of the patients. We need to have a way to proactively assess how they’re doing every single week or every single month.”
HealthPROMISE was tested during a two-year trial sponsored by the National Institutes of Health. During the trial, 320 patients with IBD were prescribed with app-based digital technologies to aid in their care. The patients were randomly placed into two groups: one group of 158 patients was assigned a basic medical education app, while a second group of 162 patients was provided with HealthPROMISE.
After 575 days, it was found that the 320 patients had significant improvement in IBD specific quality of life measures. However, patients prescribed with HealthPROMISE were found to have reported a significantly higher quality of life. Uncontrolled anxiety and fatigue were the primary factors when participants reported poor quality of life. Furthermore, app usage data showed that about 75 percent of HealthPROMISE users continued to log in and update PROs throughout the duration of the study.
According to Dr. Atreja, patients who used HealthPROMISE felt they had an ongoing relationship with their physician, even outside of the clinical setting. Dr. Atreja said that continued contact between patients and their care teams was a factor for continued engagement with HealthPROMISE, resulting in patients using the platform regularly.
Rx.Health’s RxUniverse was selected as one of the top 15 app-based medical solutions worldwide in advance of the 2017 MEDICA App Competition, which is recognized as the world’s leading trade fair for the medical industry. In order to be considered, apps must be novel, solve a large and unmet need, be scalable internationally, and pass the scrutiny of the conference’s jury panel. This year’s panel was comprised of nearly a dozen leading healthcare leaders and innovators from around the globe.
On Nov. 15, Rx.Health CEO Ed Berde will travel to Dusseldorf, Germany to present at the conference and meet with leaders from health systems, payers and the pharmaceutical industry interested in promoting innovation through RxUniverse’s unique platform approach, which can integrate multiple solutions under one workflow.
“This is further validation for RxUniverse and how it can harness the power of tremendous innovation happening worldwide and transform care by integrating and delivering those solutions to the hands of patients at right time to deliver the right outcomes,” Berde said “Our selection at MEDICA speaks to a global appeal for this platform and we will be looking to further expand on our meaningful partnerships with key international players.”
Click here for the full press release.
Rx.Health is proud to support the 2017 Annual American Informatics Association Conference in Washington, D.C. During the conference, which is held from Nov. 4 through Nov. 8, Dr. Ashish Atreja will be presenting the results of the RxUniverse pilot study that was conducted at the Mount Sinai Health System.
“AMIA assembles the perfect audience to present the pilot study of RxUniverse, so this presentation should be incredibly exciting,” Dr. Atreja said. “Attendees understand that informatics are a crucial and necessary component of advancing healthcare to a patient-centric methodology. Digital Medicine is at the forefront of this progression, and we now have the statistics and evidence to support that statement.”
RxUniverse’s six-week pilot study was conducted with the goal of prescribing 100 mobile health apps to patients. Exceeding test result expectancies by more than 200 percent, the pilot study involved 40 clinicians and health care providers at five clinical sites at Mount Sinai. Clinicians prescribed over 2,000 mobile health apps during the trial period, and RxUniverse received an 84.2 score on the System Usability Scale. SUS is used to evaluate technology products and compare them to industry standards of usability and learnability.
This SUS score places RxUniverse in the top 96 percentile of technology products. The statistics resulting from the RxUniverse pilot study provides further evidence that a platform approach to engaging patients using Digital Medicine is a valuable tool in bridging the gap between innovation in health care and patient engagement.
AMIA actively supports research and practice in healthcare informatics and offers a platform for professionals, students and patients to come together and discuss the future of informatics in healthcare. Over the last 35 years, informatics have grown exponentially to improve health, and are key to accelerating the current goals of healthcare reform.
To learn more, view the press release here.